Nanostring Technologies reported $45.81M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agilent A:US USD 5.61B 304M
Becton, Dickinson and BDX:US USD 25.47B 190M
Bio Rad Laboratories BIO:US USD 9.62B 1.16B
Bio Techne TECH:US USD 1.83B 75.95M
Bruker BRKR:US USD 1.13B 188.7M
Catalent CTLT:US USD 4.91B 212M
Charles River Laboratories CRL:US USD 2.98B 349.44M
Danaher DHR:US USD 50.08B 3.1B
Exact Sciences EXAS:US USD 3.04B 65.47M
Fluidigm FLDM:US USD 229.79M 18.72M
Hologic HOLX:US USD 5.09B 216.3M
Illumina ILMN:US USD 6.6B 132M
IQVIA Holdings Inc IQV:US USD 5.76B 418M
Mettler Toledo International MTD:US USD 24.79M 107.6M
Myriad Genetics MYGN:US USD 885.8M 30.8M
Nanostring Technologies NSTG:US USD 45.81M 37.11M
Pacific Biosciences Of California PACB:US USD 562.9M 63.69M
Perkinelmer PKI:US USD 7.39B 327.68M
Repligen RGEN:US USD 1.91B 75.59M
Roche Holding ROG:VX 27.99B 2.8B
Thermo Fisher Scientific TMO:US USD 44.03B 483M
Waters WAT:US USD 504.49M 119.25M